Overview
- 4 inspections across 4 sites are on record.
- 16 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2016-11-18.
At a glance
Inspections
4
Sites
4
Observations
16
Career since
Dec 2011
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Q LABS, LLC | 18 Nov 2016 | Human Drugs | View 483 → |
| Teva Womens Health, LLC | 4 Jun 2012 | View 483 → | |
| Elanco UK AH Limited | 15 Dec 2011 | ||
| Emott AG | 8 Dec 2011 |
Sites inspected
Q LABS, LLCCincinnati, United States1 insp.
Teva Womens Health, LLCCincinnati, United States1 insp.
Elanco UK AH LimitedLiverpool, United Kingdom1 insp.
Emott AGGockhausen, Switzerland1 insp.
Co-investigators
Investigators who share inspections with this person.
Robert C Steyert2 shared
Lauren N Smith1 shared
Lauren N Howard1 shared
Lindsey M Schwierjohann1 shared
Joshua S Hunt1 shared
Michael P Sheehan1 shared
Full investigator report
Get the verbatim findings behind David S Jackson's 16 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site